Money Lancer
Equity: Sectoral-Pharma and Healthcare
DSP Mutual Fund
DSP Mutual Fund · Equity: Sectoral-Pharma and Healthcare

DSP Healthcare Fund - Regular Plan - Growth

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved

EquityBenchmark · BSE Healthcare TRITER · 1.92%Inception · 05-11-2018
NAV
44.17
-0.35% · as of 14-07-2026
Since inception
21.45%
CAGR
Benchmark (inception)
14.99%
CAGR
Fund size
₹3,514 Cr
AUM
Expense ratio
1.92%
31-05-2026
Performance

Returns vs benchmark & category

Since inception: +21.45% CAGR vs benchmark +14.99%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-8.35%
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-7.81%
CIPLA LIMITED EQ NEW FV RS.2/-7.68%
ILLUMINA INC7.53%
Sai Life Sciences Limited6.86%
TREPS / Reverse Repo Investments6.47%
Globus Medical Inc6.34%
GLAND PHARMA LIMITED EQ NEW FV Re.1/-6.26%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-4.81%
SUVEN PHARMACEUTICALS LIMITED EQ4.15%

Sector allocation

Healthcare74.36%
Financial Services1.31%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 21.4% p.a.
₹10,000
10 years
Projected value
₹42,03,457
Invested: ₹12,00,000
Gained: ₹30,03,457
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
C
Chirag Dagli
Manager since fund inception data not available
ISIN & identifiers
AMFI code
145456
ISIN (Growth)
INF740KA1LD8
ISIN (Div Re-inv)
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us